Severe hypocalcaemia after being given intravenous bisphosphonate.
Peter
Rajesh
R
Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3GA.
Mishra
Vinita
V
Fraser
William D
WD
D001862:Bone Resorption / Q000517:prevention & control; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006996:Hypocalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid